Chinese medicinal composition as well as preparation method and application thereof
A composition and technology of traditional Chinese medicine, applied in the field of traditional Chinese medicine composition, can solve problems such as decreased sperm motility, ICSI failure, sperm-egg fusion and decreased fertilization ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0147] Preparation method of pharmaceutical composition
[0148] The pharmaceutical composition of the present invention can be prepared by conventional methods. In one embodiment, it includes the steps:
[0149] (1) Mix the necessary components or their extracts to obtain a mixture. The necessary components are (a) 15-90 parts by weight containing a traditional Chinese medicine that provides sperm motility energy, and the traditional Chinese medicine that provides sperm motility energy includes wolfberry Seeds, raspberries and dangshen; (b) 15-60 parts by weight of traditional Chinese medicine for strengthening adenosine triphosphate, said traditional Chinese medicine for strengthening adenosine triphosphate including Chinese yam; (c) 70-330 parts by weight of traditional Chinese medicine with antioxidant effect, said antioxidant The effective Chinese medicines include angelica, astragalus, white peony root, schisandra, dodder, rehmannia, cornus, tortoise shell, turtle shell, Shou...
Embodiment 1—3
[0169] Preparation of pharmaceutical composition
[0170]
[0171]
[0172] Mix the above-mentioned medicinal materials according to the formula amount. The first water addition is the total weight of the medicinal materials (g)×10ml, and the simmer is 40-50 minutes; the second water addition is the total weight of the medicinal materials (g)×6ml, and the simmer is 30-35 minutes. . Each dose is decocted twice, and after mixing, the pharmaceutical composition (decoction) of the present invention is obtained in a total of about 300 ml.
Embodiment 4
[0174] Pharmacodynamic test of pharmaceutical composition
[0175] 1. Materials and methods
[0176] 1.1 Research objects and groups
[0177] Selected from March 2005 to March 2007, infertile patients with severe oligozoospermia (non-obstructive spontaneous ejaculation) who were treated at Shanghai Family Planning Research Institute of Shanghai Fudan University School of Medicine and Shanghai Ruijin Hospital Reproductive Medicine Center 155 example. The patients were divided into two groups according to the different treatment methods:
[0178] 1. ICSI group (n=77), because of the prevention of ovarian hyperstimulation (OHSS), 5 patients gave up the transplant cycle, and 2 of the 72 patients experienced severe ovarian hyperstimulation;
[0179] 2. ICSI+Chinese medicine group (n=82). Because of the prevention of ovarian hyperstimulation (OHSS), 4 patients gave up the transplant cycle. 78 patients in the transplant cycle did not have severe ovarian hyperstimulation. The general informa...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com